Can a smartphone app save mothers from preeclampsia in pakistan?

NCT ID NCT05662696

Recruiting now Knowledge-focused Sponsor: University Health Network, Toronto Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is testing whether a mobile phone app can help pregnant women at high risk for preeclampsia in Karachi, Pakistan, monitor their blood pressure and symptoms at home. Fifty women will use the app to send daily readings to their healthcare team, who can then respond if needed. The goal is to see if this approach is practical and acceptable in a low-resource setting, not yet to prove it prevents complications.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Raabta Telemonitoring Program (mobile application)
What this could lead to: If successful, this could show that a simple mobile app is a practical way to monitor high-risk pregnancies in low-resource settings, potentially reducing maternal deaths from preeclampsia.
What could go wrong: This is a very small, early feasibility study with only 50 participants in one city. It is not designed to prove the app prevents complications, only that it might be usable.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PREECLAMPSIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

preeclampsia pregnancy disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PREECLAMPSIA PREGNANT WITH COMPLICATION

Contacts and locations

Locations

Jinnah Postgraduate Medical Centre
RECRUITING

Karachi, Sindh, 75510, Pakistan

More trials for these conditions

Other studies related to the condition(s) this trial covers.